Target intelligence / Profile preview

Lower urinary tract sensory pathways (LUT sensory pathways)

Target
LUT sensory pathways
Molecular classification
Other
01

Overview

The lower urinary tract (LUT) sensory pathways, often referred to as the urinary tract mucosal sensory pathways, constitute a complex signaling network involving the urothelium, suburothelial interstitial cells, and afferent nerve fibers (A-delta and C-fibers) (Yoshimura et al., 2008). The urothelium acts as a primary sensor, responding to mechanical stretch and chemical stimuli by releasing various mediators such as adenosine triphosphate (ATP), acetylcholine (ACh), and nitric oxide (NO) (Birder et al., 2001). These mediators then activate receptors on suburothelial nerves, including purinergic (P2X3), vanilloid (TRPV1), and muscarinic receptors, which transmit sensory information to the central nervous system to regulate the micturition reflex (Andersson, 2019). Dysregulation of these pathways, often characterized by increased sensitivity or 'afferent sensitization,' is a key factor in the pathophysiology of conditions like overactive bladder (OAB), interstitial cystitis, and bladder pain syndrome (Kanai & Andersson, 2010). Pharmacological interventions targeting these pathways aim to modulate sensory input, using agents such as TRPV1 agonists (for desensitization), P2X3 antagonists, or muscarinic antagonists to alleviate symptoms of urgency and pain (Andersson, 2019; Grundy et al., 2025).

Other names
Urinary tract mucosal sensory pathwaysBladder mucosal sensory signalingUrothelial-afferent pathwaysMicturition reflex afferent limbLower urinary tract afferent pathways
02

Mechanism of action

Modulation of afferent signaling through desensitization of TRPV1-expressing sensory fibers, antagonism of P2X3 purinergic receptors, activation of beta-3 adrenergic receptors, and blockade of muscarinic receptors on the urothelium and suburothelial nerves.

03

Biological functions

Signal transductionSensory perceptionMicturition reflex regulationMechanotransduction
04

Disease associations

Overactive bladderInterstitial cystitisBladder pain syndromeUrinary incontinenceNeurogenic detrusor overactivity
05

Safety considerations

Hyperthermia (associated with TRPV1 antagonism)Urinary retentionDry mouthConstipationBlurred visionInjection site pain
06

Interacting drugs

Capsaicin

7 more in the full profile.

07

Biomarkers

Urinary Nerve Growth Factor (NGF)Urinary Adenosine Triphosphate (ATP)Urothelial TRPV1 expression levelsUrinary Prostaglandin E2 (PGE2)

Beyond the preview

Go deeper on Lower urinary tract sensory pathways (LUT sensory pathways).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lower urinary tract sensory pathways (LUT sensory pathways).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call